State Street’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$31.7M Buy
3,915,336
+224,982
+6% +$1.82M ﹤0.01% 1931
2025
Q1
$30.9M Sell
3,690,354
-7,792
-0.2% -$65.3K ﹤0.01% 1890
2024
Q4
$29.3M Buy
3,698,146
+183,425
+5% +$1.45M ﹤0.01% 2000
2024
Q3
$29.2M Buy
3,514,721
+127,753
+4% +$1.06M ﹤0.01% 1994
2024
Q2
$21.5M Buy
3,386,968
+442,770
+15% +$2.81M ﹤0.01% 2130
2024
Q1
$17.8M Buy
2,944,198
+145,141
+5% +$880K ﹤0.01% 2245
2023
Q4
$17M Buy
2,799,057
+463,947
+20% +$2.82M ﹤0.01% 2291
2023
Q3
$9.85M Buy
2,335,110
+104,373
+5% +$440K ﹤0.01% 2605
2023
Q2
$6.92M Buy
2,230,737
+100,768
+5% +$312K ﹤0.01% 2837
2023
Q1
$2.96M Buy
2,129,969
+35,648
+2% +$49.6K ﹤0.01% 3190
2022
Q4
$4.17M Sell
2,094,321
-37,818
-2% -$75.3K ﹤0.01% 3111
2022
Q3
$4.31M Sell
2,132,139
-476,223
-18% -$962K ﹤0.01% 3139
2022
Q2
$8.3M Buy
2,608,362
+161,817
+7% +$515K ﹤0.01% 2836
2022
Q1
$10.2M Sell
2,446,545
-39,808
-2% -$166K ﹤0.01% 2813
2021
Q4
$11.9M Sell
2,486,353
-43,444
-2% -$208K ﹤0.01% 2820
2021
Q3
$13.5M Sell
2,529,797
-209,018
-8% -$1.12M ﹤0.01% 2705
2021
Q2
$14M Buy
2,738,815
+303,813
+12% +$1.56M ﹤0.01% 2713
2021
Q1
$16.4M Sell
2,435,002
-200,268
-8% -$1.35M ﹤0.01% 2482
2020
Q4
$12M Buy
2,635,270
+142,237
+6% +$650K ﹤0.01% 2523
2020
Q3
$9.67M Sell
2,493,033
-282,898
-10% -$1.1M ﹤0.01% 2451
2020
Q2
$13.2M Buy
2,775,931
+358,789
+15% +$1.71M ﹤0.01% 2264
2020
Q1
$8.41M Buy
2,417,142
+146,620
+6% +$510K ﹤0.01% 2378
2019
Q4
$10.9M Buy
2,270,522
+424,083
+23% +$2.04M ﹤0.01% 2478
2019
Q3
$5.36M Sell
1,846,439
-284,408
-13% -$825K ﹤0.01% 2752
2019
Q2
$15.3M Buy
2,130,847
+190,355
+10% +$1.36M ﹤0.01% 2271
2019
Q1
$27.5M Sell
1,940,492
-98,901
-5% -$1.4M ﹤0.01% 1838
2018
Q4
$27.6M Sell
2,039,393
-25,317
-1% -$343K ﹤0.01% 1760
2018
Q3
$45.8M Buy
2,064,710
+186,737
+10% +$4.14M ﹤0.01% 1585
2018
Q2
$30.8M Buy
+1,877,973
New +$30.8M ﹤0.01% 1835